Prostatic Neoplasms, Castration-Resistant

4 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Prostatic Neoplasms, Castration-Resistant
Treatment and conditionWhere it standsTrials
Androgen receptor signaling inhibitor (ARSI) + VIR-5500 for prostatic neoplasms, castration-resistantPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Androgen receptor signaling inhibitor (ARSI) + VIR-5500 + DOCETAXEL for prostatic neoplasms, castration-resistantPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Omeprazole 80 mg twice daily for prostatic neoplasms, castration-resistantPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
VIR-5500 for prostatic neoplasms, castration-resistantPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1